Filing Details
Forte Biosciences, Inc. (NASDAQ:FBRX) filed a Form 8-K with the Securities and Exchange Commission on July 27, 2026, disclosing a material event.
8k filedNASDAQ:FBRX
Forte Biosciences, Inc. (FBRX) Reports Material Event to SEC
Filing Details Forte Biosciences, Inc. (NASDAQ:FBRX) filed a Form 8-K with the Securities and Exchange Commission on July 27, 2026, disclosing a material event. Market Context…
Market Context
Forte Biosciences, Inc.'s stock currently trades at $76.50 with a market capitalization of $284.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Forte Biosciences, Inc.'s stock.
All SEC filings for Forte Biosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View FBRX Stock Page
Frequently Asked Questions
Where can I read FBRX's SEC filings?
Browse all filings on our FBRX SEC filings page.
What types of SEC filings does Forte Biosciences, Inc. file?
Public companies like Forte Biosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.